ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every regulatory approval announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
417 announcements with these filters
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.
KFin Technologies' Thai subsidiary received a Foreign Business License from Thailand's Ministry of Commerce. The license enables the subsidiary to conduct permitted business activities under local law.
AAVAS Financiers received an IRDAI Certificate of Registration to act as a Corporate Agent, effective December 8, 2026, and perpetual subject to annual fees. The approval lets the company solicit insurance products to its customers.
Lehar Footwears received a BIS licence on October 23, 2026 under IS 17043 for its 'Shoes for General Purpose' product. The licence is a government product approval that lets the company proceed with this product.
DiGiSPICE's material subsidiary Spice Money received RBI in-principle authorisation to operate as a Payment Aggregator-Physical. Final authorisation follows fulfilment of RBI conditions within the stipulated timeline.
JK Digital, a Jaykay WOS, received a CDSCO licence to manufacture eight Class C/D orthopaedic and spinal implants. The lifetime licence expands the company's medical devices portfolio.
Zydus Lifesciences received USFDA approval for its Estradiol-Levonorgestrel Transdermal System ANDA, designated as a CGT. The product is eligible for 180-day exclusivity upon first commercial marketing.
Dr. Reddy's received DCGI approval for Zytorvi in advanced esophageal cancer, its second Indian indication. This expands first-line immunotherapy access in its oncology portfolio.
Nuvama Asset Management, a subsidiary of the company, received SEBI approval to establish a Specialized Investment Fund, enabling the launch of its Numa SIF platform.
Alembic Pharmaceuticals received USFDA final approval for Ciprofloxacin and Dexamethasone Otic Suspension USP. This drug is therapeutically equivalent to the reference product Ciprodex Otic Suspension.
Omaxe Ltd received RERA registration for its 'Eternity - 2' commercial and service apartment project in Mathura. The approval facilitates sales, marketing, and project development.
RBL Bank has received RBI approval for the amalgamation of Emirates NBD Bank's Indian branches. The integration is effective from December 01, 2026.
Ganesha Ecosphere's subsidiary received FSSAI approval to manufacture food-grade rPET at its fourth production line in Warangal, Telangana.
Venus Remedies Limited secured five marketing authorizations for drugs including Vancomycin and Meropenem across Kazakhstan, Peru, Kuwait, and Argentina. These regulatory approvals expand its global pharmaceutical portfolio.
Zim Laboratories received TGA GMP certification from Australia's Therapeutic Goods Administration for its Nagpur manufacturing facility. The certification covers various dosage forms and is valid until June 2028.
RBI approved variable pay and fixed remuneration for Suryoday Bank's MD & CEO and Whole-time Director. Shareholders had earlier ratified the package at the 18th AGM.
Vraj Iron and Steel received a fresh ToR from MoEF&CC for its greenfield Raipur steel plant. The multi-component facility includes DRI kilns, induction furnaces and rolling mills.
IRDAI has approved the appointment of Mr. Sidharatha Mishra as the new Managing Director & CEO of ICICI Life Insurance Limited, effective October 14, 2026.
Cohance Lifesciences received Central Government approval for the appointment of Mr. Umang Vohra as Chairman and Group CEO.
Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.
Lupin Limited received U.S. FDA approval for its Abbreviated New Drug Application (ANDA) for Phytonadione Injectable Emulsion, USP (1 mg/0.5 mL single-dose prefilled syringe).
Vedavaag Systems' subsidiary, Vedavaag Financial Insurance Broking Services, received in-principle approval from IRDAI to operate as a Direct Insurance Broker.
Mukka Proteins received a USDA NOP attestation from ECOCERT for its organic fertilizer. The certification supports marketability in US organic farming markets through March 2028.
B N Rathi Securities received SEBI approval for Merchant Banker registration (INM000013581). This expands the company's regulatory license portfolio for merchant banking activities.
Indiabulls Limited received a Certificate of Registration from the Reserve Bank of India to operate as a Core Investment Company.
Vibrant Global Capital's subsidiary, The Private Reserrve Capital, received SEBI registration for TPR Wealth Trust as a Category III Alternative Investment Fund. This allows the group to expand into AIF management.
India Cements Capital Limited received RBI approval for the change in management control or ownership of more than 50 percent, in relation to the ongoing open offer.
Beacon Trusteeship's subsidiary, Beacon Investor Holdings, received SEBI approval to operate as a trading member on the Metropolitan Stock Exchange (MSEIL).
Repono Limited's step-down subsidiary received North Central Railway approval for the Engineering Scale Plan of its proposed Gati Shakti Cargo Terminal. This clearance enables construction at Ajhai Station.